Adhoc: Relief Therapeutics Holding SA: Relief Reports Half-Y

Relief Therapeutics Holding SA / Key word(s): Interim Report Relief Reports Half-Year 2022 Results and Provides Corporate Update 15-Sep-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant

Related Keywords

Geneva , Genè , Switzerland , Secheron , Switzerland General , United States , United Kingdom , Swiss , Christopher Wick , Anthony Kim , Michael Miller , Advita Lifescience Gmbh , Jack Weinstein , Raghuram Selvaraju , David Mccullough , Relief Therapeutics Holding Sa Key , Rx Communications Group , Meta Healthcare Ltd , Nasdaq , Nasdaq Stock Exchange , Swiss Exchange Listing , Acer Therapeutics Inc , News Service , Pharma Research , European Commission , Swiss Exchange , Nrx Pharmaceuticals , Exchange Commission , Swiss Financial Services , Key Clinical Development , International Journal Of Molecular Sciences , Relief Therapeutics Holding , Securities Exchange , Neurorx Inc , Swiss Patent Office , Reports Half Year , Provides Corporate Update , Provides Corporate , Executive Director , Drew Cronin Fine , Senior Director , Senior Vice President , Meta Healthcare , Acer Therapeutics , New Drug Application , Prescription Drug User Fee Act , Marketing Authorization Application , Investigational New Drug , Maple Syrup Urine Disease , Orphan Drug Designation , Nasdaq Stock Market , Clinical Development Highlights , International Journal , Molecular Sciences , Patent Application , Complete Response Letter , United Kingdom Based , Intestinal Peptide , Drug Induced Pneumonitis , Use Diclofenac Packs , Serene Forte , Genetic Medicine , Registration Statement , Securities Exchange Act , Securities Act , American Depositary Shares , Nasdaq Stock , Six Months Ended June , License Agreement , Urea Cycle Disorders , Financial Officer , Communications Group , Swiss Financial Services Act , Exchange Listing , Adhoc , Relief , Herapeutics , Molding , Reports , Calf , Ear , 022 , Results , Rovides , Corporate , Update ,